Analysis of the Cost-Effectiveness of Liquid Biopsy to Determine Treatment Change in Patients with Her2-Positive Advanced Breast Cancer in Colombia

Overview of attention for article published in ClinicoEconomics and Outcomes Research: CEOR, February 2020

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 21 Dimensions

Readers on

mendeley: 65 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 3 X posts from 2 X users, with an upper bound of 749 followers.

RT @SandraPhD: ¿Vale la pena seguir pacientes con cáncer de seno en Colombia usando una prueba molecular🧬en sangre💉? Por ahora no...Analysi…

12 Feb 2020

Reply Repost Favourite

Is it worth to follow up breast cancer patients with a 🧬💉non invasive test in Colombia? Not today....Analysis of the Cost-Effectiveness of Liquid Biopsy to Determine Treat | CEOR @DovePress https://t.co/JTQmG1g7Cn

12 Feb 2020

Reply Repost Favourite

¿Vale la pena seguir pacientes con cáncer de seno en Colombia usando una prueba molecular🧬en sangre💉? Por ahora no...Analysis of the Cost-Effectiveness of Liquid Biopsy to Determine Treat | CEOR @DovePress https://t.co/JTQmG1g7Cn

12 Feb 2020

Reply Repost Favourite

Dove Medical Press

Article Metrics

Analysis of the Cost-Effectiveness of Liquid Biopsy to Determine Treatment Change in Patients with Her2-Positive Advanced Breast Cancer in Colombia

About this Attention Score

Mentioned by

Citations

Readers on